Capricor Therapeutics Files 8-K
Ticker: CAPR · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1133869
| Field | Detail |
|---|---|
| Company | Capricor Therapeutics, Inc. (CAPR) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: CAPR
TL;DR
CAPR filed an 8-K on March 19th for financial updates.
AI Summary
Capricor Therapeutics, Inc. filed an 8-K on March 19, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates Capricor Therapeutics is providing updates on its financial status and operational results to the SEC, which is important for investors to monitor the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not appear to contain any immediately alarming or significant new risks.
Key Players & Entities
- CAPRICOR THERAPEUTICS, INC. (company) — Registrant
- March 19, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-34058 (filing_id) — Commission File Number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text for the 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but it does not include the specific financial figures or operational details within the excerpt.
When was this 8-K filing submitted by Capricor Therapeutics?
The filing was submitted on March 19, 2025.
What is the Commission File Number for Capricor Therapeutics?
The Commission File Number for Capricor Therapeutics is 001-34058.
In which state was Capricor Therapeutics incorporated?
Capricor Therapeutics was incorporated in Delaware.
What are the primary items reported in this 8-K filing?
This 8-K filing reports on the Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding CAPRICOR THERAPEUTICS, INC. (CAPR).